Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis
Journal of Zhejiang University-SCIENCE B · 2023
DOI: 10.1631/jzus.b2200385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Zhejiang University-SCIENCE B, 2023. Verfasst von Mai A Abd-Elmawla und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt. mei.abdelmawla@pharma.cu.edu.eg. Hauptthemen laut MEDLINE: Inflammasomes, Pulmonary Fibrosis. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science, Technology & Innovation Funding Authority (STDF) in cooperation with the Egyptian Knowledge Bank (EKB).
Abstract (Originalsprache)
Ivermectin is a US Food and Drug Administration (FDA)-approved antiparasitic agent with antiviral and anti-inflammatory properties. Although recent studies reported the possible anti-inflammatory activity of ivermectin in respiratory injuries, its potential therapeutic effect on pulmonary fibrosis (PF) has not been investigated. This study aimed to explore the ability of ivermectin (0.6 mg/kg) to alleviate bleomycin-induced biochemical derangements and histological changes in an experimental PF rat model. This can provide the means to validate the clinical utility of ivermectin as a treatment option for idiopathic PF. The results showed that ivermectin mitigated the bleomycin-evoked pulmonary injury, as manifested by the reduced infiltration of inflammatory cells, as well as decreased the inflammation and fibrosis scores. Intriguingly, ivermectin decreased collagen fiber deposition and suppressed transforming growth factor-β1 (TGF-β1) and fibronectin protein expression, highlighting its anti-fibrotic activity. This study revealed for the first time that ivermectin can suppress the nucleotide-binding oligomerization domain (NOD)-like receptor family pyrin domain-containing protein 3 (NLRP3) inflammasome, as manifested by the reduced gene expression of NLRP3 and the apoptosis-associated speck-like protein containing a caspase recruitment domain ( ASC ), with a subsequent decline in the interleukin-1β (IL-1β) level. In addition, ivermectin inhibited the expression of intracellular nuclear factor-κB (NF-κB) and hypoxia-inducible factor-1α (HIF-1α) proteins along with lowering the oxidative stress and apoptotic markers. Altogether, this study revealed that ivermectin could ameliorate pulmonary inflammation and fibrosis induced by bleomycin. These beneficial effects were mediated, at least partly, via the downregulation of TGF-β1 and fibronectin, as well as the suppression of NLRP3 inflammasome through modulating the expression of HIF-1α and NF-κB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt. mei.abdelmawla@pharma.cu.edu.eg.
- Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt. heba.mosalam@pharma.cu.edu.eg.
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Sinai University, Ismailia 45511, Egypt.
- Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Cairo 12211, Egypt.
- Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.
Förderung
- Science, Technology & Innovation Funding Authority (STDF) in cooperation with the Egyptian Knowledge Bank (EKB)
Zitieren
APA
Abd-Elmawla, M. A., Ghaiad, H. R., Gad, E. S., Ahmed, K. A., & Abdelmonem, M. (2023). Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis. Journal of Zhejiang University-SCIENCE B. https://doi.org/10.1631/jzus.b2200385
Vancouver
Abd-Elmawla MA, Ghaiad HR, Gad ES, Ahmed KA, Abdelmonem M. Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis. Journal of Zhejiang University-SCIENCE B. 2023. doi:10.1631/jzus.b2200385
BibTeX
@article{AbdElmawla2023,
author = {Abd-Elmawla, Mai A and Ghaiad, Heba R and Gad, Enas S and Ahmed, Kawkab A and Abdelmonem, Maha},
title = {Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis},
journal = {Journal of Zhejiang University-SCIENCE B},
year = {2023},
doi = {10.1631/jzus.b2200385}
}
EUVIMED